Synthetic nucleic acid sequence screening is the set of checks used to review DNA or RNA orders before they are synthesized. Screening systems compare requested sequences against known hazard databases, look for patterns linked to pathogens, toxins, or other regulated biology, and may apply rules based on sequence similarity, customer identity, or order behavior.
This matters in cyber security because modern bio-AI can generate novel sequences that are not exact matches for anything already cataloged. A weak filter may miss a dangerous design if it is sufficiently new, while a strong program can slow abuse by flagging suspicious orders for human review or blocking them outright. In practice, effective screening is layered: automated matching, policy controls, logging, escalation, and manual assessment. As generative biology becomes more capable, screening shifts from simple blacklist checking to an adaptive defense problem, much like malware detection that must keep up with new variants.